We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-3.83%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$821M
AUM Growth
+$121M
Cap. Flow
+$149M
Cap. Flow %
18.12%
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$135M
2
REVH
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
+$13.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.38%
2 Financials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$369M 44.91%
2,912,872
– –
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$170M 20.77%
36,335,375
– –
DNLI icon
3
Denali Therapeutics
DNLI
$3.67B
$152M 18.54%
+5,168,749
New +$135M
ERAS icon
4
Erasca
ERAS
$6.66B
$61.6M 7.5%
11,055,554
– –
VERV
5
DELISTED
Verve Therapeutics
VERV
$38.3M 4.67%
2,508,809
– –
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$14.5M 1.77%
126,631
– –
REVH
7
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$13.3M 1.62%
+1,357,237
New +$13.3M
MTCR
8
DELISTED
Metacrine, Inc. Common Stock
MTCR
$1.47M 0.18%
2,940,503
– –
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
$298K 0.04%
349,908
– –
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
$147K 0.02%
119,205
– –

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q2 2022 Portfolio in Review

As of Q2 2022, Arch Venture Management held 10 positions worth $821M, up 17% from $700M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management deployed $149M of net new capital in Q2 2022, opening 2 new positions. Its largest new stake was Denali Therapeutics: 5,168,749 shares worth $152M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 100% a quarter earlier, followed by Financials.

  • Arch Venture Management's largest Q2 2022 buy was Denali Therapeutics: 5,168,749 shares worth $152M.
  • Arch Venture Management's ten largest holdings make up 100% of its $821M portfolio in Q2 2022.
  • Arch Venture Management opened 2 new positions and closed 0 in Q2 2022.
  • Arch Venture Management's portfolio value rose 17% quarter-over-quarter to $821M.

Based on Arch Venture Management's 13F filing for Q2 2022, filed 15 Aug 2022.